Ascletis Pharma Inc. (1672.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.95B |
| Enterprise Value | 8.51B |
| P/E Ratio | -7.95 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 5,199.58 |
| Price/Book Ratio | 2.15 |
| Enterprise/Revenue | 4,577.06 |
| Enterprise/EBITDA | -6.67 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -625.08 |
| Operating Margin | -703.95 |
AD
Management Effectiveness
| Return On Assets | -0.24 |
| Return On Equity | -0.28 |
Income Statement
| Revenue | 2.03M |
| Revenue/Share | 0 |
| Gross Profit | 527,000 |
| EBITDA | -466.92M |
| Net Income | -359.88M |
| Diluted EPS | -0.37 |
Balance Sheet
| Total Cash | 2.27B |
| Total Cash/Share | 2.18 |
| Total Debt | 3.74M |
| Total Debt/Equity | 0 |
| Current Ratio | 12.92 |
| Book Value Per Share | 2.19 |
Price History
| 52-Week Change | -40.12 |
| 52-Week High | 19.86 |
| 52-Week Low | 5.4 |
| Moving Average 50 Days | 8.95 |
| Moving Average 200 Days | 12.58 |
Statistics
| Average Volume | 2.41M |
| Shares Outstanding | 1.05B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
